|
|
||||||||
Ann Thorac Surg 1994;57:1044-1050
© 1994 The Society of Thoracic Surgeons
Department of Surgery, Duke University Medical Center, Durham, North Carolina, USA
* Address reprint requests to Dr Lowe, Duke University Medical Center, PO Box 3954, Durham, NC 27710.
Mucormycosis is an opportunistic fungal infection that commonly begins by invading the respiratory tract. The purpose of the present study was to define the clinical presentation of pulmonary mucormycosis and to evaluate current treatment regimens. Thirty patients treated at our institution and 225 cases reported in the literature were reviewed. For the combined groups, the mean age at presentation was 41 ± 21 years and associated medical conditions included leukemia or lymphoma (37%), diabetes mellitus (32%), chronic renal failure (18%), history of organ transplantation (7.6%), or a known solid tumor (5.6%). The in-hospital mortality was 65% for patients with isolated pulmonary mucormycosis, 96% for those with disseminated disease, and 80% overall. The mortality in patients treated surgically was 11%, significantly lower than the 68% mortality in those treated medically (p = 0.0004). The most common causes of death were fungal sepsis (42%), respiratory insufficiency (27%), and hemoptysis (13%). Pulmonary mucormycosis has a high mortality; however, antifungal agents appear to improve survival. In addition, surgical resection may provide additional benefit to patients with pulmonary mucormycosis confined to one lung.
This article has been cited by other articles:
![]() |
G. Petrikkos, A. Skiada, O. Lortholary, E. Roilides, T. J. Walsh, and D. P. Kontoyiannis Epidemiology and Clinical Manifestations of Mucormycosis Clinical Infectious Diseases, February 1, 2012; 54(suppl_1): S23 - S34. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. P. Kontoyiannis and R. E. Lewis How I treat mucormycosis Blood, August 4, 2011; 118(5): 1216 - 1224. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Quan and B. Spellberg Mucormycosis, Pseudallescheriasis, and Other Uncommon Mold Infections Proceedings of the ATS, May 15, 2010; 7(3): 210 - 215. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Chakrabarti, R. S. K. Marak, M. R. Shivaprakash, S. Gupta, R. Garg, V. Sakhuja, S. Singhal, A. Baghela, A. Dixit, M. K. Garg, et al. Cavitary Pulmonary Zygomycosis Caused by Rhizopus homothallicus J. Clin. Microbiol., May 1, 2010; 48(5): 1965 - 1969. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Shenoi and H. Emery Successful treatment of invasive gastric mucormycosis in a child with systemic lupus erythematosus Lupus, April 1, 2010; 19(5): 646 - 649. [Abstract] [PDF] |
||||
![]() |
C. G. Koshy, S. Shah, and T. Mammen Subcutaneous emphysema of the chest: could it be pulmonary mucormycosis? Thorax, March 1, 2010; 65(3): 280 - 280. [Full Text] [PDF] |
||||
![]() |
A Chakrabarti, S S Chatterjee, A Das, N Panda, M R Shivaprakash, A Kaur, S C Varma, S Singhi, A Bhansali, and V Sakhuja Invasive zygomycosis in India: experience in a tertiary care hospital Postgrad. Med. J., November 1, 2009; 85(1009): 573 - 581. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. J. C. Goldstein, B. Spellberg, T. J. Walsh, D. P. Kontoyiannis, J. Edwards Jr, and A. S. Ibrahim Recent Advances in the Management of Mucormycosis: From Bench to Bedside Clinical Infectious Diseases, June 15, 2009; 48(12): 1743 - 1751. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Kasai, S. M. Harrington, A. Francesconi, V. Petraitis, R. Petraitiene, M. G. Beveridge, T. Knudsen, J. Milanovich, M. P. Cotton, J. Hughes, et al. Detection of a Molecular Biomarker for Zygomycetes by Quantitative PCR Assays of Plasma, Bronchoalveolar Lavage, and Lung Tissue in a Rabbit Model of Experimental Pulmonary Zygomycosis J. Clin. Microbiol., November 1, 2008; 46(11): 3690 - 3702. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Brown Zygomycosis: An emerging fungal infection Am. J. Health Syst. Pharm., December 15, 2005; 62(24): 2593 - 2596. [Abstract] [Full Text] [PDF] |
||||
![]() |
M Karanth, P Taniere, J Barraclough, and J A Murray A rare presentation of zygomycosis (mucormycosis) and review of the literature J. Clin. Pathol., August 1, 2005; 58(8): 879 - 881. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Spellberg, J. Edwards Jr., and A. Ibrahim Novel Perspectives on Mucormycosis: Pathophysiology, Presentation, and Management Clin. Microbiol. Rev., July 1, 2005; 18(3): 556 - 569. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. J. Reid, D. L. Solnik, T. Daskalakis, and K. P. Sheka Management of Bronchovascular Mucormycosis in a Diabetic: A Surgical Success Ann. Thorac. Surg., October 1, 2004; 78(4): 1449 - 1451. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. R. Pauls, J. G. Ravenel, and M. A. Judson A Neutropenic Patient With Rapidly Progressive Lung Lesion Chest, October 1, 2004; 126(4): 1364 - 1367. [Full Text] [PDF] |
||||
![]() |
J. S. William and A. S. David Review of Newer Antifungal and Immunomodulatory Strategies for Invasive Aspergillosis Clinical Infectious Diseases, October 1, 2003; 37(Supplement_3): S157 - S187. [Abstract] [Full Text] [PDF] |
||||
![]() |
M.-L. Virally, J.-P. Riveline, J. Virally, P. Chevojon, J.-F. Regnard, A. Belmekki, and A. Devidas Pulmonary Mucormycosis in a Diabetic Patient with HIV Diabetes Care, November 1, 2002; 25(11): 2105 - 2105. [Full Text] [PDF] |
||||
![]() |
Y. Zaizen and T. Ohtsu Successful treatment of pulmonary mucormycosis, a rare pulmonary fungal infection, in a patient with diabetes mellitus J. Thorac. Cardiovasc. Surg., October 1, 2002; 124(4): 838 - 840. [Full Text] [PDF] |
||||
![]() |
E. Dannaoui, J. Afeltra, J. F. G. M. Meis, and P. E. Verweij In Vitro Susceptibilities of Zygomycetes to Combinations of Antimicrobial Agents Antimicrob. Agents Chemother., August 1, 2002; 46(8): 2708 - 2711. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. R. Donado-Una, V. Diaz-Hellin, A. Lopez-Encuentra, and J. M. Echave-Sustaeta Persistent cavitations in pulmonary mucormycosis after apparently successful amphotericin B Eur J Cardiothorac Surg, May 1, 2002; 21(5): 940 - 942. [Abstract] [Full Text] [PDF] |
||||
![]() |
Diabetes and rapidly advancing pneumonia Postgrad. Med. J., November 1, 2001; 77(913): 736c - 736. [Full Text] [PDF] |
||||
![]() |
Y. J. Hong, D. Y. Lee, and Y. S. Park Pulmonary Mucormycosis Asian Cardiovasc Thorac Ann, June 1, 2001; 9(2): 146 - 149. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. Rickerts, A. Bohme, A. Viertel, G. Behrendt, V. Jacobi, K. Tintelnot, and G. Just-Nubling Cluster of Pulmonary Infections Caused by Cunninghamella bertholletiae in Immunocompromised Patients Clinical Infectious Diseases, October 1, 2000; 31(4): 910 - 913. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Mawatari, M. Nakamura, T. Koshino, K. Kusajima, T. Abe, K. Tsunematsu, H. Sugawara, I. Takeya, T. Mawatari, M. Nakamura, et al. Combined Medical and Surgical Treatment for Pulmonary Mucormycosis Asian Cardiovasc Thorac Ann, June 1, 2000; 8(2): 183 - 185. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. A. Ribes, C. L. Vanover-Sams, and D. J. Baker Zygomycetes in Human Disease Clin. Microbiol. Rev., April 1, 2000; 13(2): 236 - 301. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Glazer, S. Nusair, R. Breuer, J. Lafair, Y. Sherman, and N. Berkman The Role of BAL in the Diagnosis of Pulmonary Mucormycosis* Chest, January 1, 2000; 117(1): 279 - 282. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Mendoza-Ayala, R. Tapia, and M. Salathe Spontaneously Resolving Pulmonary Mucormycosis Clinical Infectious Diseases, November 1, 1999; 29(5): 1335 - 1336. [Full Text] [PDF] |
||||
![]() |
F. Y. W. Lee, S. B. Mossad, and K. A. Adal Pulmonary Mucormycosis: The Last 30 Years Arch Intern Med, June 28, 1999; 159(12): 1301 - 1309. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. R. Andrews, A. Allan, and R. I. Larbalestier Tracheal Mucormycosis Ann. Thorac. Surg., January 1, 1997; 63(1): 230 - 232. [Abstract] [Full Text] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |